CVE-2026-21923 Missing authorization in Oracle Life Sciences Central Designer

Medium 6.5 Published 20 Jan 2026 Updated 21 Jan 2026

Unauthenticated attackers can read and modify data in Oracle Life Sciences Central Designer via HTTP.

Exploited in the wild: Not known
Login needed: Not needed
Attackable: Over the internet
Victim action needed: Not needed
Fix: None listed

What is CVE-2026-21923?

CVE-2026-21923 is a medium-severity missing authorization vulnerability in Oracle Life Sciences Central Designer, published on 20 Jan 2026. An attacker can exploit it over the internet without logging in, with no action from the victim.

Official description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Which versions are affected by CVE-2026-21923?

It affects 1 product.

Products include Oracle Life Sciences Central Designer.

How do I fix CVE-2026-21923?

No fix has been published for CVE-2026-21923 yet. Limit exposure of the affected software until one is available.

Upgrade, and check permissions on every request on the server, not only in the interface. More about Missing authorization.

Is CVE-2026-21923 being exploited?

There is no known exploitation of CVE-2026-21923 in the wild and no public exploit code.

Sources

Also known as GHSA-fj76-ww29-89p7.